{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Shu W"],"funding":["The Natural Science Foundation of Guangdong Province","The Fifth Affiliated Hospital of Sun Yat-sen University Qingdong Cao's talent-attracting fund"],"pagination":["7609"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9654546"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["27(21)"],"pubmed_abstract":["Esophageal squamous cell carcinoma (ESCC) is one of the most lethal malignancies globally. Peptide-based tumor-targeted imaging is critical for ESCC imaging. In this study, we aim to identify a peptide-targeting IGF2BP2 that specifically binds to human ESCC for near-infrared imaging of esophageal cancer. Applying phage display techniques, we identified a peptide target for IGF2BP2 which was confirmed to be highly expressed in ESCC cell lines or tumor tissue and may serve as an imaging target for ESCC. We conjugated the peptide to the NIRF group, Cy5, and further evaluated the targeting efficacy of the probe at a cellular level and in animal tumor models. The Cy5 conjugated peptide (P12-Cy5) showed a high binding affinity to human ESCC cells in vitro. In vivo, optical imaging also validated"],"journal":["Molecules (Basel, Switzerland)"],"pubmed_title":["Identification of an IGF2BP2-Targeted Peptide for Near-Infrared Imaging of Esophageal Squamous Cell Carcinoma."],"pmcid":["PMC9654546"],"funding_grant_id":["220904094208","2022A1515012509"],"pubmed_authors":["Li Z","Shu W","Xiao Y","Liang M","Wang L","Wu X","Cao Q"],"additional_accession":[]},"is_claimable":false,"name":"Identification of an IGF2BP2-Targeted Peptide for Near-Infrared Imaging of Esophageal Squamous Cell Carcinoma.","description":"Esophageal squamous cell carcinoma (ESCC) is one of the most lethal malignancies globally. Peptide-based tumor-targeted imaging is critical for ESCC imaging. In this study, we aim to identify a peptide-targeting IGF2BP2 that specifically binds to human ESCC for near-infrared imaging of esophageal cancer. Applying phage display techniques, we identified a peptide target for IGF2BP2 which was confirmed to be highly expressed in ESCC cell lines or tumor tissue and may serve as an imaging target for ESCC. We conjugated the peptide to the NIRF group, Cy5, and further evaluated the targeting efficacy of the probe at a cellular level and in animal tumor models. The Cy5 conjugated peptide (P12-Cy5) showed a high binding affinity to human ESCC cells in vitro. In vivo, optical imaging also validated","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Nov","modification":"2025-04-25T23:25:28.03Z","creation":"2025-04-06T09:23:37.107Z"},"accession":"S-EPMC9654546","cross_references":{"pubmed":["36364436"],"doi":["10.3390/molecules27217609"]}}